Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Covid Calls

Vaccine Scheduling Update: We’re experiencing very high call volumes from people interested in getting the COVID-19 vaccine. Currently, our vaccine supply is very small, and we are unable to accept phone calls to schedule vaccine appointments. Please check back here for updates.

1st Annual Intraoperative Molecular Imaging Precision Surgery Meeting to be held in Philadelphia

In collaboration with the World Molecular Imaging Society, Penn’s Abramson Cancer Center and the Center for Precision Surgery will host a meeting to review and discuss recent progress in intraoperative molecular imaging clinical trials and future challenges for the technology in cancer surgery. 

The Intraoperative Molecular Imaging Precision Surgery 1st Annual Clinical Trials Update will take place November 2nd, 2018 at the Perelman Center for Advanced Medicine in Philadelphia. Registration for this CME-certified event is open.

Emphasis on Fluorescent Imaging in Clinical Trials

“This conference is different because it’s focused entirely on intraoperative molecular imaging clinical trials for cancer surgery,” says neurosurgeon John Y.K. Lee, MD, MSCE. “It’s really quite inspiring because so much progress has been made in recent years in molecular imaging for cancers of the lung, breast, brain and ovary.” 

Dr. Lee will co-host the meeting with Sunil Singhal, MD, the developer of TumorGlow®, a fluorescent technology that relies on an injectable dye engineered to accumulate expressly in cancerous tissues. The dye glows under certain types of light to highlight remnant cancer cells and tumors that might otherwise escape detection. 

TumorGlow and other recent developments in lighting, dye and imaging technology will be featured throughout the meeting. 

The relative novelty of fluorescent imaging will be reflected in the afternoon session, which is devoted to a review of phase I and II clinical trials of intraoperative imaging devices and components, techniques and applications in the context of cancer surgery. 

Additionally, as it is a newer technology, a practical overview of opportunities for creation of surgeon billing codes (CPT) for intraoperative molecular imaging will also be covered.

Who should attend?

This continuing education conference is intended for surgical oncologists, neurosurgeons, thoracic surgeons, gynecologic oncology surgeons, gastrointestinal surgeons and otorhinolaryngologists/head and neck cancer surgeons. 

Other healthcare providers, technicians and clinical teams involved in fluorescence-guided surgery for cancer resections, such as radiologists, physicists, engineers, research scientists and technologists, are welcome. 

Consult with Penn Medicine

About this Blog

The Penn Physician Blog is a resource for health care professionals featuring Penn Medicine physicians and their research, innovations, programs and events. 

Date Archives

Share This Page: